|
[1]
|
Frequency and Factors Associated With Adverse Events Among Multi-Drug Resistant Tuberculosis Patients in Pakistan: A Retrospective Study
Frontiers in Medicine,
2022
DOI:10.3389/fmed.2021.790718
|
|
|
|
|
[2]
|
Xpert MTB/RIF Improves the Prognosis of Multidrug-Resistant Tuberculosis Patients Through Faster Diagnosis and Earlier Targeted Treatment: A Prospective Cohort Study
Microbial Drug Resistance,
2022
DOI:10.1089/mdr.2021.0149
|
|
|
|
|
[3]
|
Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study
Frontiers in Pharmacology,
2022
DOI:10.3389/fphar.2022.883483
|
|
|
|
|
[4]
|
Characteristics and contributing factors of adverse drug reactions: an analytical study of patients with tuberculosis receiving treatment under the National TB Program of India
F1000Research,
2022
DOI:10.12688/f1000research.125815.1
|
|
|
|
|
[5]
|
Characteristics and contributing factors of adverse drug reactions: an analytical study of patients with tuberculosis receiving treatment under the National TB Program of India
F1000Research,
2022
DOI:10.12688/f1000research.125815.1
|
|
|
|
|
[6]
|
Characteristics and contributing factors of adverse drug reactions: an analytical study of patients with tuberculosis receiving treatment under the National TB Program of India
F1000Research,
2022
DOI:10.12688/f1000research.125815.1
|
|
|
|
|
[7]
|
Ambispective study of adverse drug reactions in multi-drug resistant tuberculosis patients in Warangal, Telangana
Lung India,
2021
DOI:10.4103/lungindia.lungindia_118_19
|
|
|
|
|
[8]
|
Second-line injectable induced ototoxicity in drug resistant tuberculosis: A systematic review of Indian studies
Indian Journal of Tuberculosis,
2019
DOI:10.1016/j.ijtb.2019.04.007
|
|
|
|
|
[9]
|
Risk Factors of Gout in MDR-TB Patients in Eritrea: A Case-Control Study
Tuberculosis Research and Treatment,
2019
DOI:10.1155/2019/9429213
|
|
|
|
|
[10]
|
Integration of drug safety monitoring in tuberculosis treatment programmes: country experiences
European Respiratory Review,
2019
DOI:10.1183/16000617.0115-2018
|
|
|
|
|
[11]
|
Adverse drug reactions and treatment outcome analysis of DOTS-plus therapy of MDR-TB patients at district tuberculosis centre: A four year retrospective study
Lung India,
2017
DOI:10.4103/0970-2113.217569
|
|
|
|
|
[12]
|
Natural Remedies against Multi-Drug Resistant Mycobacterium tuberculosis
Journal of Tuberculosis Research,
2015
DOI:10.4236/jtr.2015.34024
|
|
|
|